U.S. federal trademark · Serial No. 99118774 · Reg. No. UK00004114969
Immunoassay reagents for medical use; Pharmaceutical products for the prevention and treatment of cancer; vaccines for the treatment of cancer; vaccines for the prevention of cancer; antigens in the nature of tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; vaccines for regulating the immune system; pharmaceutical preparations for treatment in the nature of regulating the immune system; proteins with diagnostic and therapeutic uses, namely arrays and solutions of proteins for diagnosing cancer and diseases and disorders of the immune system; Antibodies for medical purposes; vaccines for the prevention and treatment of immune system related diseases and disorders
Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; monoclonal antibodies for scientific purposes; nucleotides for scientific and research use; Chemicals, reagents and substances being peptides, nucleic acids and buffers for medical research purposes; proteins, namely arrays, monoclonal antibodies and enzymes for scientific and research use
Research and development in the field of cancer; research and development in the field of immunology; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the field of immunology; Biological research services; Pharmaceutical research services; pharmaceutical, biologic and immunological drug and vaccine development services; providing scientific research information and data relating to oncology and immunology; advisory and consultancy services related to scientific research in the fields of oncology oncology and immunology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.